Proton-pump inhibitor overuse: a cautionary tale in misguided benefit - PubMed (original) (raw)

Comment

Proton-pump inhibitor overuse: a cautionary tale in misguided benefit

Karthik Nath et al. Intern Med J. 2019 Oct.

No abstract available

PubMed Disclaimer

Comment on

• Is there a role for proton pump inhibitor prophylaxis in haematology patients?
  Leitinger E, Hui L, Grigg A. Leitinger E, et al. Intern Med J. 2019 Jun;49(6):694-701. doi: 10.1111/imj.14241. Intern Med J. 2019. PMID: 30719802 Review.

Similar articles

• Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor.
  Harewood GC, Gostout CJ. Harewood GC, et al. Gastrointest Endosc. 2003 Oct;58(4):493-9. doi: 10.1016/s0016-5107(03)01889-3. Gastrointest Endosc. 2003. PMID: 14520279
• Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
  You JH, Lee AC, Wong SC, Chan FK. You JH, et al. Aliment Pharmacol Ther. 2003 Mar 15;17(6):785-92. doi: 10.1046/j.1365-2036.2003.01526.x. Aliment Pharmacol Ther. 2003. PMID: 12641500
• Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
  Enns RA, Gagnon YM, Rioux KP, Levy AR. Enns RA, et al. Aliment Pharmacol Ther. 2003 Jan;17(2):225-33. doi: 10.1046/j.1365-2036.2003.01412.x. Aliment Pharmacol Ther. 2003. PMID: 12534407
• Are higher doses of proton pump inhibitors better in acute peptic bleeding?
  Villalón A, Olmos R, Rada G. Villalón A, et al. Medwave. 2016 Jun 24;16 Suppl 2:e6476. doi: 10.5867/medwave.2016.6476. Medwave. 2016. PMID: 27390875 Review. English, Spanish.
• Proton-pump inhibitors in acid-related diseases.
  Berardi RR, Welage LS. Berardi RR, et al. Am J Health Syst Pharm. 1998 Nov 1;55(21):2289-98. doi: 10.1093/ajhp/55.21.2289. Am J Health Syst Pharm. 1998. PMID: 9825880 Review. No abstract available.

Cited by

• Pepsin and Laryngeal and Hypopharyngeal Carcinomas.
  Yin CY, Zhang SS, Zhong JT, Zhou SH. Yin CY, et al. Clin Exp Otorhinolaryngol. 2021 May;14(2):159-168. doi: 10.21053/ceo.2020.00465. Epub 2020 Jul 24. Clin Exp Otorhinolaryngol. 2021. PMID: 32734742 Free PMC article. Review.

References

1. 1. Leitinger E, Hui L, Grigg A. Is there a role for proton pump inhibitor prophylaxis in haematology patients? Intern Med J 2019; 49: 694-701.
2. 1. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008; 336: 2-3.
3. 1. Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016; 176: 238-46.
4. 1. Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016; 27: 3153-63.
5. 1. Ganguli A, Sawinski D, Berns JS. Kidney diseases associated with haematological cancers. Nat Rev Nephrol 2015; 11: 478-90.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley